Medications

Could cyber designs deliver potent dual-action antibiotics?

Computational modeling has been used to create dual-action compounds with exciting potential as new antibiotics. The proof of principle experiment raises the possibility of new antibiotics that can target harmful bacteria ...

Diseases, Conditions, Syndromes

Researchers validate preclinical effectiveness of TB drug target

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten ...